Gene Therapy, Antisense Show Gains in Spinal Muscular Atrophy

Share this post

An antisense oligonucleotide drug and gene therapy each extended survival and led to attainment of motor milestones in some children with spinal muscular atrophy.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply